GlassScriptPhysician profile
Farhan Ahmed
NPI 1396978797
$16,923.83
in general payments reported to CMS, 2019-2025
36 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $260 · 2021: $244 · 2022: $225 · 2023: $521 · 2024: $4,890 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,350 · Education: $4,000 · Travel and Lodging: $2,611 · Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,350.00 |
| Education | $4,000.00 |
| Travel and Lodging | $2,610.80 |
| Food and Beverage | $1,703.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,845.06 | 2019-2025 | Ofev, Jascayd |
| Intuitive Surgical, INC. | $6,063.10 | 2024-2025 | |
| United Therapeutics Corporation | $338.19 | 2022-2025 | Tyvaso, Tyvaso |
| Glaxosmithkline, LLC. | $266.96 | 2019-2023 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $144.80 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Pulmonx Corporation | $142.15 | 2020 | |
| Philips North America LLC | $102.38 | 2019 | |
| Medtronic, INC. | $98.64 | 2023 | Illumisite |
| Takeda Pharmaceuticals U.S.A., INC. | $80.57 | 2022-2025 | Glassia, Hyqvia |
| Mylan Specialty L.P. | $76.12 | 2019-2024 | Yupelri |
| Inogen, INC. | $75.82 | 2023-2024 | Inogen |
| Merck Sharp & Dohme LLC | $72.51 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Mallinckrodt Hospital Products INC. | $52.17 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $51.95 | 2021-2023 | Uptravi, Opsumit |
| Verona Pharma, INC. | $47.63 | 2025 | Ohtuvayre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $45.09 | 2019-2025 | Dupixent |
| Alexion Pharmaceuticals, INC. | $39.83 | 2019-2020 | |
| Abiomed | $38.05 | 2024 | Impella |
| Pfizer INC. | $36.33 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $33.56 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $26.04 | 2024 | Lumryz |
| Genzyme Corporation | $23.00 | 2025 | |
| Axsome Therapeutics, INC. | $22.89 | 2023 | Sunosi |
| Astellas Pharma US INC | $22.62 | 2019 | |
| Baxter Healthcare | $18.68 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Bard Peripheral Vascular, INC. | $18.61 | 2023 | |
| Insmed, INC. | $17.87 | 2022 | |
| Sanofi Pasteur INC. | $17.62 | 2019 | |
| Shionogi INC | $15.18 | 2023 | Fetroja |
| Electromed, INC. | $14.64 | 2024 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $14.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.12 | 2019 | |
| Boston Scientific Corporation | $12.70 | 2023 | Exalt Model D |
| Genentech USA, INC. | $12.49 | 2019 | |
| Phadia US INC. | $11.86 | 2022 | |
| Portola Pharmaceuticals, LLC | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.